Calcium Pyrophosphate Deposition Disease: Historical Overview and Potential Gaps

Overview

Journal Front Med (Lausanne)

Specialty General Medicine

Date 2024 Apr 19

PMID 38638938

Authors

Carlos Pineda

Hugo Sandoval

Ivan Perez-Neri

Carina Soto-Fajardo

Fabian Carranza-Enriquez

Affiliations

Soon will be listed here.

Citing Articles

Ultrasonography in the assessment of calcium pyrophosphate deposition disease.

Yinh J, Jarraya M, Guermazi A Skeletal Radiol. 2025; .

PMID: 39918638 DOI: 10.1007/s00256-025-04883-9.

Synovial Membrane Is a Major Producer of Extracellular Inorganic Pyrophosphate in Response to Hypoxia.

Velot E, Sebillaud S, Bianchi A Pharmaceuticals (Basel). 2024; 17(6).

PMID: 38931405 PMC: 11206467. DOI: 10.3390/ph17060738.

References

Ciricillo S, Weinstein P . Foramen magnum syndrome from pseudogout of the atlanto-occipital ligament. Case report. J Neurosurg. 1989; 71(1):141-3. DOI: 10.3171/jns.1989.71.1.0141. View

Latourte A, Ea H, Frazier A, Blanchard A, Liote F, Marotte H . Tocilizumab in symptomatic calcium pyrophosphate deposition disease: a pilot study. Ann Rheum Dis. 2020; 79(8):1126-1128. DOI: 10.1136/annrheumdis-2020-217188. View

Resnick D, Niwayama G, Goergen T, Utsinger P, Shapiro R, Haselwood D . Clinical, radiographic and pathologic abnormalities in calcium pyrophosphate dihydrate deposition disease (CPPD): pseudogout. Radiology. 1977; 122(1):1-15. DOI: 10.1148/122.1.1. View

Rothschild B, Yakubov L . Prospective 6-month, double-blind trial of hydroxychloroquine treatment of CPDD. Compr Ther. 1997; 23(5):327-31. View

Coari G, Iagnocco A, Zoppini A . Chondrocalcinosis: sonographic study of the knee. Clin Rheumatol. 1995; 14(5):511-4. DOI: 10.1007/BF02208146. View

Tedeschi S, Cai T, He Z, Ahuja Y, Hong C, Yates K . Classifying Pseudogout Using Machine Learning Approaches With Electronic Health Record Data. Arthritis Care Res (Hoboken). 2020; 73(3):442-448. PMC: 7338229. DOI: 10.1002/acr.24132. View

KOHN N, Hughes R, McCarty Jr D, FAIRES J . The significance of calcium phosphate crystals in the synovial fluid of arthritic patients: the "pseudogout syndrome". II. Identification of crystals. Ann Intern Med. 1962; 56:738-45. DOI: 10.7326/0003-4819-56-5-738. View

Gomez H, Chou S . Myeloradiculopathy secondary to pseudogout in the cervical ligamentum flavum: case report. Neurosurgery. 1989; 25(2):298-302. DOI: 10.1097/00006123-198908000-00024. View

Utsinger P, Resnick D, Zvaifler N . Wrist arthropathy in calcium pyrophosphate dihydrate deposition disease. Arthritis Rheum. 1975; 18(5):485-91. DOI: 10.1002/art.1780180509. View

10.

Zhang W, Doherty M, Pascual E, Barskova V, Guerne P, Jansen T . EULAR recommendations for calcium pyrophosphate deposition. Part II: management. Ann Rheum Dis. 2011; 70(4):571-5. DOI: 10.1136/ard.2010.139360. View

11.

Abhishek A, Doherty S, Maciewicz R, Muir K, Zhang W, Doherty M . Chondrocalcinosis is common in the absence of knee involvement. Arthritis Res Ther. 2012; 14(5):R205. PMC: 3580517. DOI: 10.1186/ar4043. View

12.

MARTEL W, Champion C, Thompson G, Carter T . A roentgenologically distinctive arthropathy in some patients with the pseudogout syndrome. Am J Roentgenol Radium Ther Nucl Med. 1970; 109(3):587-605. DOI: 10.2214/ajr.109.3.587. View

13.

Fuerst M, Lammers L, Schafer F, Niggemeyer O, Steinhagen J, Lohmann C . Investigation of calcium crystals in OA knees. Rheumatol Int. 2009; 30(5):623-31. DOI: 10.1007/s00296-009-1032-2. View

14.

Martinon F, Petrilli V, Mayor A, Tardivel A, Tschopp J . Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature. 2006; 440(7081):237-41. DOI: 10.1038/nature04516. View

15.

McCarty D, HOLLANDER J . Identification of urate crystals in gouty synovial fluid. Ann Intern Med. 1961; 54:452-60. DOI: 10.7326/0003-4819-54-3-452. View

16.

Filippou G, Scire C, Adinolfi A, Damjanov N, Carrara G, Bruyn G . Identification of calcium pyrophosphate deposition disease (CPPD) by ultrasound: reliability of the OMERACT definitions in an extended set of joints-an international multiobserver study by the OMERACT Calcium Pyrophosphate Deposition Disease.... Ann Rheum Dis. 2018; 77(8):1194-1199. DOI: 10.1136/annrheumdis-2017-212542. View

17.

Zitnan D, Sitaj S . [Chondrocalcinosis polyarticularis (familiaris): roentgenological and clinical analysis]. Cesk Rentgenol. 1960; 14:27-34. View

18.

McGonagle D, Tan A, Madden J, Emery P, McDermott M . Successful treatment of resistant pseudogout with anakinra. Arthritis Rheum. 2008; 58(2):631-3. DOI: 10.1002/art.23119. View

19.

Hutton C, Doherty M, Dieppe P . Acute pseudogout of the temporomandibular joint: a report of three cases and review of the literature. Br J Rheumatol. 1987; 26(1):51-2. DOI: 10.1093/rheumatology/26.1.51. View

20.

Filippou G, Scire C, Damjanov N, Adinolfi A, Carrara G, Picerno V . Definition and Reliability Assessment of Elementary Ultrasonographic Findings in Calcium Pyrophosphate Deposition Disease: A Study by the OMERACT Calcium Pyrophosphate Deposition Disease Ultrasound Subtask Force. J Rheumatol. 2017; 44(11):1744-1749. DOI: 10.3899/jrheum.161057. View